This content is machine translated 10 years GIST Group Switzerland GIST – a life with cancer Since 2004, the patient organization “GIST Group Switzerland” (www.gist.ch) has been supporting patients with gastrointestinal stromal tumors (GIST) and their families. This year’s annual meeting offered a special program for…
View Post 2 min This content is machine translated On our own account We stand for topicality Dear readers
View Post 3 min This content is machine translated WCM Congress Basal cell carcinoma – What therapies are available for advanced forms? New avenues in the treatment of basal cell carcinoma (BCC) are being intensively discussed by current researchers. In particular, the functioning and inhibition of the Hedgehog signaling pathway offers an…
View Post 3 min This content is machine translated Oral tumor therapy Preliminary results of a pilot project to improve patient communication. The pilot project “Patient communication in oral tumor therapy to promote adherence” will evaluate whether targeted communication training for nurses and physicians adds value for patients and the healthcare professionals…
View Post 4 min This content is machine translated Chronic lymphocytic leukemia New therapies urgently needed At the ESMO Congress in Amsterdam, speakers from various countries discussed the latest results and therapy recommendations in the field of chronic lymphocytic leukemia. Overall, chemoimmunotherapy with fludarabine, cyclophosphamide (FC),…
View Post 5 min This content is machine translated Non-Hodgkin's Lymphoma “The new drugs will fundamentally change the therapeutic landscape” In an interview with InFo ONCOLOGY & HEMATOLOGY, Prof. Christoph Driessen, MD, Head Physician of the Department of Oncology/Hematology at the Cantonal Hospital St. Gallen, provides information on the pathogenesis,…
View Post 4 min This content is machine translated Hematology New possibilities thanks to targeted therapy At the DGHO congress in Vienna, the focus was on new targeted therapies designed to improve the quality of life of patients with malignant hematologic diseases. In particular, medical advances…
View Post 6 min This content is machine translated 5th Interdisciplinary Prostate Cancer Symposium Metastatic prostate cancer – New therapeutic options Prostate cancer is the most common male tumor in Western countries and is the second leading cause of cancer-related death in Switzerland. In particular, metastatic castration-resistant prostate cancer (mCRPC) is…
View Post 1 min This content is machine translated Metastatic colorectal carcinoma Determination of mutational RAS status is important in mCRC The results of the FIRE-3 study, presented at this year’s European Cancer Congress in Amsterdam, emphasize the importance and relevance of RAS mutation analysis (KRAS and NRAS) for first-line treatment…
View Post 11 min This content is machine translated Stop smoking Information for daily practice It is undisputed that smoking is harmful and among the most important causes of premature morbidity and mortality. Because of the serious health consequences, smoking cessation counseling is important and…
View Post 9 min This content is machine translated Benign prostatic hyperplasia Comparison of different therapy methods While a great many 60- to 80-year-olds have prostatic hyperplasia, only about 40% of them show symptoms that include obstructive and irritative micturition symptoms. The following article discusses which examinations…
